ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CHIR-98014, a GSK 3β Inhibitor, Protects Against Triptolide/Lipopolysaccharide-Induced Hepatotoxicity by Mitochondria-Dependent Apoptosis Inhibition

Zhou, Shaoyun; Cheng, Ruohan; Zhang, Yue; Jiang, Yihan; Zhang, Luyong*; Jiang, Zhenzhou*; Yu, Qinwei*广东药学院
Chemical Research in Toxicology2024-1-29DOI: 10.1021/acs.chemrestox.3c00367
9阅读
引用收藏
分享

摘要

Triptolide (TP) is a remarkable anti-inflammatory and immunosuppressive component separated from Tripterygium wilfordii Hook. F. However, its hepatotoxicity limits its application in the clinical. Our group has proposed a new perspective on TP-induced hepatotoxicity, in which TP enhances liver hypersensitivity upon lipopolysaccharide (LPS) stimulation. Because the cause of the disease is unknown, there is currently no uniform treatment available. In this study, we attempted to determine whether the GSK-3 beta-JNK pathway affects liver damage and its regulatory mechanism in response to TP/LPS costimulation. In addition, we investigated the effect of CsA or the GSK 3 beta inhibitor CHIR-98014 on TP/LPS-induced hepatotoxicity. The results showed that the TP/LPS cotreatment mice exhibited obvious hepatotoxicity, as indicated by a remarkable increase in the serum ALT and AST levels, glycogen depletion, GSK 3 beta-JNK upregulation, and increased apoptosis. Instead of the specific knockdown of JNK1, the specific knockdown of JNK2 had a protective effect. Additionally, 40 mg/kg of CsA and 30 mg/kg of CHIR-98014 might provide protection. In summary, CHIR-98014 could protect against TP/LPS- or TP/TNF-alpha-induced activation of the GSK 3 beta-JNK pathway and mitochondria-dependent apoptosis, improving the indirect hepatotoxicity induced by TP.

学科与关键词

关键词
CYCLOSPORINE-ALIVER-INJURYTRIPTOLIDEKINASEPERMEABILIZATIONTRANSLOCATIONACTIVATION
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Chemical Research in Toxicology
发表日期
2024-01-29
卷期
第 37 卷, 第 2 期
页码
407-418
DOI
10.1021/acs.chemrestox.3c00367
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82274200, 82074114, 81973562]; Double First-Class University project [CPU2018GY33]; China Postdoctoral Science Foundation [2020M681786]

作者

  • Z

    Zhou, Shaoyun (第一作者)

    china pharmaceut univ · new

  • C

    Cheng, Ruohan

    china pharmaceut univ · new

查看全部 7 位作者收起作者
  • Z

    Zhang, Yue

    china pharmaceut univ · new

  • J

    Jiang, Yihan

    china pharmaceut univ · new

  • Z

    Zhang, Luyong (通讯)

    guangdong pharmaceut univ · china pharmaceut univ · new

  • J

    Jiang, Zhenzhou (通讯)

    china pharmaceut univ · new

  • Y

    Yu, Qinwei (通讯)

    china pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417